financial estimates
Chembio Diagnostics Q2 Revenues Rise 27 Percent; Firm Conducts Going Concern Evaluation
The firm said its revenues did not meet its expectations and were a principal cause of limited cash and cash-equivalents position at the end of the quarter.
PerkinElmer to Acquire BioLegend for $5.25B; Q2 Revenues Rise 51 Percent
The BioLegend deal, the largest in PerkinElmer's history, is expected to provide $.30 of adjusted earnings per share in the first full year following the close of the deal.
Natera Reports Preliminary Q2 Revenue Growth of Around 60 Percent
The company expects its women's health unit will be its first business to achieve cash flow breakeven operations in Q2.
Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent
The diagnostics segment was negatively impacted by supply chain issues with reagents causing back orders toward the end of the quarter.
Qiagen Reports Preliminary Q2 Revenues Above Guidance; Adjusts FY21 Expectations Downward
The company's preliminary revenues and EPS beat prior guidance and analysts' estimates as lower COVID-19 test sales were tempered by growth in core products.
Feb 11, 2021
LabCorp Q4 Revenues Rise 52 Percent
Feb 2, 2021
PerkinElmer Q4 Revenues Spike 68 Percent
Jan 13, 2021
OpGen Preliminary Q4 Revenue Climbs 63 Percent
Jan 11, 2021
Invitae 2020 Preliminary Revenues Rise 28 Percent
Jan 11, 2021